Luminary Life Sciences to present innovations in reproductive genetics at ASRM 2025 Scientific Congress & Expo
Presentations will highlight advances in genetic testing, embryo transfer outcomes, and patient access to reproductive care.
SAN ANTONIO, TX [October 24, 2025] – Luminary Life Sciences, a leader in genetic testing and reproductive technology, will present multiple studies at the American Society for Reproductive Medicine (ASRM) 2025 Scientific Congress & Expo. This year’s research showcases innovations in reproductive genetics, with topics spanning monogenic causes of infertility, the role of PGT-A and PGT-SR testing, embryo transfer outcomes, and new approaches to PGT-M test creation. Visit the Luminary Life Sciences team at booth 1621 to learn more about leading-edge new products like PGT-A Link and LinkPlus.
Highlights of Luminary’s standout innovations at ASRM 2025 include:
Monogenic Causes of Infertility: Moving Beyond the Basics – Clinical session presented by Sydney Bunshaft, M.S., LCGC (Tuesday, October 28, 10:45–11:45 AM CT).
The Incidental Utility of PGT-A Testing: A PGT-SR Case Review – Poster presentation by Debra Paul, M.S., LCGC (Tuesday, October 28, 4:00 PM CT).
A Single Center’s Experience with Euploid and Non-Euploid Embryo Transfer – Poster presentation in collaboration with SDFC, presented by Said Daneshmand, M.D. (Tuesday, October 28, 3:45 PM CT).
Ploidy Identification in Preimplantation Genetic Testing for Aneuploidy (PGT-A): “True Euploidy” Rates and Clinical Outcomes of Embryos Developed from Abnormally Fertilized Oocytes – Poster presentation in collaboration with SDFC, presented by Cengiz Cinnioglu, Ph.D. (Tuesday, October 28, 3:45 PM CT).
Use of Stored DNA Samples in PGT-M Test Creation: One PGT Laboratory’s Experience – Poster presentation by Claire Jones, M.S., LCGC (Tuesday, October 28, 3:30 PM CT).
“We are constantly seeking new ways to address the challenges patients face in their fertility journey,” said Cengiz Cinnioglu, Ph.D., Founder and General Manager at Luminary Genetics. “This year’s ASRM program underscores the impact that reproductive genetics can have on both treatment outcomes and patient choice.”
“As a team, our goal is to ensure that scientific discovery translates into meaningful options for patients,” said Amy Jordan, M.S., LCGC, Director of Reproductive Genetics and head of the Genetic Counseling team at Luminary Life Sciences. “These studies reflect our continued commitment to innovation, access, and patient-centered care.”
Luminary Life Sciences invites ASRM 2025 attendees to connect with their research team and explore how advancements in reproductive genetics are shaping the future of fertility care.
About Luminary Life Sciences
Luminary Life Sciences is an expanding suite of life science services that includes genetics, vitamins, surrogacy services, and cryogenic storage solutions. The Luminary portfolio brings the next generation of scientific advancements to elevate patient care and deliver superior ancillary support to all stages of the reproductive health journey.